Appendix Table 1A.
Category | No. of combination trials |
---|---|
Adoptive immunotherapy | 2 |
Antibodies | 5 |
Antiproliferative | 2 |
CCR5 inhibitors | 2 |
Cytokines | 5 |
Gene therapies | 2 |
Latency-reversing agents | 8 |
Mammalian target of rapamycin inhibitors | 1 |
Routine vaccines | 1 |
Selective oestrogen receptor modulator | 1 |
Therapeutic vaccines | 5 |